Repligen Corporation
Repligen Corporation (RGEN) is a life sciences company providing bioprocessing technologies and solutions, with a single congressional trader executing 12 transactions in the last 12 months and $14.5M in federal contracts from the Department of Defense and HHS.
BusinessWhat RGEN does
Repligen develops and commercializes bioprocessing technologies used in the manufacture of biological drugs, including proteins, vaccines, and cell and gene therapies. Its product portfolio includes filtration, chromatography, and process analytics systems. Revenue is derived from sales to biopharmaceutical and contract development and manufacturing organizations.
12 months past · 3 months futureRGEN activity timeline
Executive Branch ConflictsRGEN held by Trump-administration officials
Lifetime Government AwardsRGEN federal contracts by year
Smart Money · 13F HoldingsHedge funds holding RGEN
Politicians Trading RGENMembers of Congress with recent RGEN positions
Congressional TradesWho in Congress is trading RGEN
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
No Form 4 activity recorded in the last 180 days.
Political ProfileWhere RGEN sits in Washington
[object Object]
STRUCTURAL: No lobbying spend (get_political_influence.lobbying.total_income: 0), no donations, low federal contract scale ($14.5M). EVIDENTIARY: Single congressional trader (Rep. McCaul) with high-frequency trading (12 transactions) but net neutral buys/sales count; no corporate insider buys in 180 days (get_corporate_insider_signal.total_buys: 0). Net: Active trading by one congressman offsets lack of structural political engagement.
Regulatory ExposureThreats & opportunities
Regulatory threats
-
FDA regulation of bioprocessing equipment and consumables as part of drug manufacturing quality systems.FDA (within HHS)"get_government_precedent.federal_contracts_summary[0].agencies includes Department of Health and Human Services, indicating regulatory interface."
Regulatory opportunities
-
Federal contracts for bioprocessing equipment supporting government health and defense research.Department of Health and Human Services, Department of Defense"get_government_precedent.federal_contracts_summary[0] shows $14.5M total obligation across 4 contracts from these agencies."
Capitol Hill AlliesChampions & critics
Congressional champions
Congressional critics
- No specific congressional critics identified.
Live signals + predictions for RGEN — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades RGEN
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord